Objective: Few studies have examined the efficacy of antiretroviral therapy (ART) in the context of cell-to-cell transmission. We aimed to determine whether the activity of ART is limited by the mode of HIV-1 spread between cells and the type of immune cell implicated in transmission, or is independent of these variables.
Introduction
Macrophages constitute up to 7% of the HIV-1-infected cell population in vivo [1] , and their contribution to HIV-1 pathogenesis is increasingly recognized [2, 3] . Multiple lines of evidence support a key role for macrophages in HIV-1 persistence: infected macrophages resist viral cytopathic effects [4] , harbour replication competent virus for weeks to months [5] , reside in tissues where antiretroviral therapy (ART) penetration is reduced [6] and are capable of efficient cell-to-cell viral transmission to uninfected CD4 þ T cells [7, 8] .
Cell-to-cell infection may increase the probability of escape from antiretroviral inhibition, and has been proposed to account for ongoing replication in the face of ART [9] , a potential explanation for viral persistence [10] . However, this proposal is controversial since others have suggested that ART has equivalent efficacy against both cell-free and cell-to-cell spread between T cells [11] . A related unanswered question that is central to this debate is whether resistance to antiretroviral inhibition is quantitative, resulting from a greater number of viruses transferred per cell [9] , or whether qualitative differences inherent to the mechanism of cell-to-cell infection between different target cell types are involved [12] . The ability of ART to control HIV-1 replication and spread is of central importance to design of ART regimens [13] , and has direct relevance to establishment and maintenance of viral reservoirs and potential HIV-1 cure [14] . For this reason, and given the potential importance of the macrophage reservoir [10] together with evidence that infected tissue macrophages persist in patients during ART [15] , we sought to establish whether cell-to-cell transmission from monocyte-derived macrophages (MDMs) to autologous primary CD4 þ T cells is amenable to antiretroviral inhibition. Our approach contrasts with previous studies that have used highly permissive reporter cell lines and/or readout of viral Gag transfer between cells that may not accurately represent productive infection in the in-vivo situation [9, 11, 16] .
Methods

Monocyte-derived macrophage isolation and infection
Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood samples from healthy HIV-1-uninfected donors by density gradient centrifugation (Histopaque; Sigma, Gillingham, Dorset, UK) and monocytes were enriched to high purity (>95% CD14 þ ) by untouched magnetic selection (MACS Monocyte Isolation Kit II; Miltenyi Biotech, Bisley, Surrey, UK). Monocytes were seeded in 24 or 96 well plates at 5 Â 10 5 cells/ml and differentiated to macrophages for 7 days in X-VIVO 10 (Lonza, Slough, Berkshire, UK) medium supplemented with 1% donor human serum as previously described [7] . MDMs were subsequently infected for 7 days [7] at varying multiplicities of infection (MOI, from 10 0 to 10 -3 ) with replicationcompetent infectious molecular clones which stably express Renilla reniformis luciferase and macrophage-tropic Env from the BaL or YU-2 isolates [17] in cis together with all HIV-1 viral proteins in an isogenic NL4.3 backbone (known as NL-LucR.T2A [17] , kindly provided by J. Kappes and C. Ochsenbauer). Viral stocks were prepared by 293T transfection with polyethyleneimine (Sigma) and titered on TZM-bl (JC53) cells as described [18] .
CD4 R T-cell isolation and infection and antiretroviral therapy treatment Autologous CD4 þ T cells were enriched from PBMCs by untouched magnetic selection (MACS CD4 þ T-cell Isolation Kit; Miltenyi Biotech) to high purity (>95% CD3 þ CD4 þ ) and stimulated for 3 days with 1 mg/ml phytohaemagglutinin (PHA; Sigma) and 10 IU/ml IL-2 (Centre for AIDS Reagents, NIBSC, Potters Bar, Hertfordshire, UK) in RPMI (PAA) with 10% foetal bovine serum (PAA) and 1% penicillin/streptomycin (Sigma) (RPMI-10) [7] . Activated CD4 þ T cells were then pre-incubated for 1 h with non-toxic concentrations of the nucleoside reverse transcriptase (RT) inhibitor azidothymidine (AZT), the non-nucleoside RT inhibitor nevirapine (NVP), the integrase inhibitor raltegravir (RAL, all from Centre for AIDS Reagents, NIBSC) prior to co-culture with infected MDMs at a donor to target cell ratio of 1 : 2, or cell-free infection at varying MOI as described [7] . Co-cultures were left static or gently shaken at 75 r.p.m. at 37 o C at 5% CO 2 [18, 19] . MDM viability under these conditions was assessed with the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) viability assay (Promega, Southampton, UK) as previously described [13] . Infections were allowed to proceed for 48 h (approximating a single cycle of replication) during which time antiretroviral drugs were maintained in the medium. At 48 h, CD4 þ T cells were gently removed (<0.1% macrophage contamination determined by flow cytometry staining for CD3 and CD14), washed in phosphate-buffered saline (PBS) and lysed with Glo-Lysis buffer (Promega). For luciferase quantification, cell lysates were mixed 1 : 1 with Ren-Glo assay solution (Promega) at room temperature and luminescence measured at 1000 ms À1 integration on a SpectroMax M5 (Molecular Devices, Wokingham, Berkshire, UK) plate reader. After subtracting background values, data were normalized to untreated controls to derive the transmission index [9] (Tx): infection drug /infection control . Antiretroviral titration data were fitted to a sigmoidal dose-response curve in GraphPad Prism 5.0 to obtain the 50% inhibitory concentration (IC 50 ). Repeat experiments in multiple independent donors were compared using t-test, one-way analysis of variance (ANOVA) with Dunnett's post-test or two-way ANOVA with Tukey's post-test, and two-tailed a less than 0.05 was considered significant. Statistical analysis was performed in Prism 5.0.
Results
Reduced antiretroviral therapy efficacy against cell-to-cell HIV-1 infection of CD4 R T cells We measured luciferase activity to quantify expression of integrated virus in CD4 þ T cells because this is a direct measure of productive infection not confounded by measuring non-infectious transfer of Gag by flow cytometry, or post-integration latency and/or the presence of non-integrated viral DNA forms by PCR.
To assess the relative efficiency of cell-to-cell and cell-free infection we first co-cultured infected MDMs and CD4 þ T cells under gentle shaking conditions (75 r.p.m.) that permit cell-free diffusion but dramatically reduce cell-tocell transmission by preventing sustained cell-cell contacts [19] , and compared the resulting infection levels to parallel co-cultures without gentle shaking. Infections were maintained for 48 h as this approximates a single cycle of infection by both cell-to-cell and cell-free routes [9, 11] . Luciferase production when cell-to-cell transmission was inhibited was approximately 20-fold lower (P < 0.001 t-test; Fig. 1a ), extending our previous observation that cell-to-cell viral transfer from macrophages is considerably more efficient [7] . Shaking had no effect on cell viability as measured by MTS assay (Fig. 1b) as has been reported previously [18, 19] . As expected, antiretroviral agents effectively inhibited conventional low-multiplicity cell-free infection at the approximate maximum plasma concentrations in patients (C max ) [20] [21] [22] . By contrast, inhibition of luciferase production after cell-to-cell transmission was significantly impaired for all antiretrovirals tested (Fig. 1c) , which was reflected in a significantly higher transmission index (Tx; Fig. 1d ).
Antiretroviral therapy efficacy is dependent upon multiplicity of infection of the target cell
We reasoned that the impaired efficacy of ART against cell-to-cell transmission could result from qualitative differences in the mechanism of viral transfer at the macrophage-T-cell interface as a result of virological synapse formation [12] , or might simply reflect a higher HIV-1 MOI by direct cell-to-cell spread compared to cell-free spread [9] . To address this, we first infected CD4 þ T cells with increasing MOI cell-free inocula in the presence or absence of AZT, which resulted in a stepwise increase in Tx, reflecting the reduced probability of inhibition with increased virus challenge ( Fig. 2a ). To directly address the effect of MOI under cell-to-cell transmission conditions, we titered macrophage-produced inocula to yield equivalent T-cell infection by the cell-free and cell-to-cell routes ( Fig. 2b and positive (POS) control in Fig. 2c ). When MOI was controlled in this way, we observed that inhibition by antiretroviral drugs was equally effective by either route (Fig. 2c,d ). Under these conditions, titration of ART in both cell-to- cell and cell-free infections demonstrated that the effectiveness of inhibition is not influenced by the mode of viral transmission across a range of antiretroviral concentrations ( Fig. 2e-h ).
Discussion
These findings have important implications for HIV-1 treatment and eradication strategies. Available evidence suggests that the enhanced efficiency of cell-to-cell transmission derives from polarized budding of HIV-1 from the donor cell towards the target cell [23] , viral receptor clustering on the target cell [7, 24] and the close proximity of donor and target cells at the virological synapse [7, 12, 18] . If cell-to-cell infection was qualitatively drug-insensitive, the implication is that efforts to drive transcription from latently infected cells under ART would fail due to uninhibited expansion of the infected cell population [9] . However, our data demonstrate that cell-to-cell infection is equally susceptible to antiretroviral inhibition when the target cell viral challenge 'dose' is equivalent, suggesting that the increased efficiency is not qualitative, but quantitative. This agrees with recent data on productive T cell-to-T cell spread [9, 11, 25] and supports the concept that aspects of HIV-1 cell-to-cell transmission relevant to antiretroviral activity are qualitatively similar to cell-free infection [12] . However, the precise mechanisms governing high-multiplicity macrophage HIV-1 transmission, particularly the molecular architecture of the synapse and the influence of target cell and viral tropic phenotype, require further definition.
In this and other model systems, MOI appears to be the principal in-vitro determinant of antiretroviral activity in the absence of resistance mutations [9, 11] . The extremely high-titre extracellular concentrations of virus needed to saturate antiretroviral activity are unlikely to be reached in vivo by cell-free spread, where virion infectivity is limited by fluid-phase dilution and diffusion coupled with rapid Env degeneration [12] . By contrast, sufficiently high multiplicities might be achieved in tissues in which target cells are densely packed, cell-to-cell transmission occurs [26, 27] and antiretroviral penetrance is reduced [6] .
